Atlas FDA

LADAR VISION TREATMENTS

FDA premarket approval P970043/S004 · decided 1999-09-24

Approval details

PMA number
P970043
Supplement
S004
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
LADAR VISION TREATMENTS
Generic name
Excimer laser system
Applicant
Alcon Laboratories
Date received
1999-08-19
Decision date
1999-09-24
Days to decision
36 days
Decision code
APPR
Product code
LZS
Advisory committee
Ophthalmic
Expedited review
No
Location
Fort Worth, TX
Statement
Approval for adding software computer screens to provide precautions when refractive parameters were entered that were outside the approved indications for use. These indications for use remain: PRK for the reduction or elimination of -1.00 to -10.00 D of spherical myopia with or without -1.00 to -4.00 D of astigmatism at the spectacle plane, the combination of which must result in an attempted correction between -0.50 and -10.00 D SE at the spectacle plane where sphere or cylinder magnitude is

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NEXT GENERATION LASER (K062624)Alcon Laboratories2007-11-05
SMALL VOLUME SYRINGE (K062865)Alcon Laboratories2007-08-23
RGP MULTI-PURPOSE SOLUTION ID 100136 (K000148)Alcon Laboratories2000-04-11
OPTI-FREE EXPRESS MULTI-ACTION CLEANING AND REWETTING DROP (K984573)Alcon Laboratories1999-09-16
OPTI-FREE SUPRACLENS DAILY PROTEIN REMOVER (K990480)Alcon Laboratories1999-05-10
MULTI-PURPOSE DISINFECTING SOLUTION ID 90746 (K984575)Alcon Laboratories1999-01-14
OPTI-ONE MULTI-PURPOSE SOLUTION (K983973)Alcon Laboratories1998-12-18
MULTI-PURPOSE DISINFECTING SOLUTION ID 90746 (K983780)Alcon Laboratories1998-12-18